Results 11 to 20 of about 2,083 (199)
ENLIGHT (European Network for Light Ion Hadron Therapy) and its role in Hadron therapy [PDF]
Health and TechnologyAbstract Purpose This study provides a comprehensive overview of the progress in hadron therapy within Europe, particularly highlighting the critical roles of the Proton Ion Medical Machine Study (PIMMS) and the European Network for Light Ion Hadron Therapy (ENLIGHT). Methods
Manjit Dosanjh, Dosanjh Manjit
exaly +5 more sources
A survey of hadron therapy accelerator technologies [PDF]
2007 IEEE Particle Accelerator Conference (PAC), 2007 Hadron therapy has entered a new age [1]. The number of facilities grows steadily, and "consumer" interest is high. Some groups are working on new accelerator technology, while others optimize existing designs by reducing capital and operating costs, and improving performance.
Todd Satogata, S Peggs
exaly +4 more sources
Hadron Therapy Physics and Simulations [PDF]
SpringerBriefs in Physics, 2014 This brief provides an in-depth overview of the physics of hadron therapy, ranging from the history to the latest contributions to the subject. It covers the mechanisms of protons and carbon ions at the molecular level (DNA breaks and proteins 53BP1 and ...
Marcos D'Avila Nunes
exaly +4 more sources
Late effects from hadron therapy [PDF]
Radiotherapy and Oncology, 2004 Successful cancer patient survival and local tumor control from hadron radiotherapy warrant a discussion of potential secondary late effects from the radiation. The study of late-appearing clinical effects from particle beams of protons, carbon, or heavier ions is a relatively new field with few data. However, new clinical information is available from
Blakely, Eleanor A., Chang, Polly Y.
openaire +5 more sources
Gamma Emission in Hadron Therapy --- Experimental Approach [PDF]
Acta Physica Polonica B, 2015 Acta physica Polonica / B 46(3), 753- (2015).
Wronska, A. +9 more
openaire +8 more sources
Helium-3 and helium-4 acceleration by high power laser pulses for hadron therapy [PDF]
Physical Review Special Topics. Accelerators and Beams, 2015 The laser driven acceleration of ions is considered a promising candidate for an ion source for hadron therapy of oncological diseases. Though proton and carbon ion sources are conventionally used for therapy, other light ions can also be utilized ...
S. S. Bulanov +7 more
doaj +2 more sources
Nasopharynaeal adenoid cystic carcinoma, a rare disease. A case report and literature review. [PDF]
Batna Journal of Medical Sciences, 2023 Nasopharyngeal adenoid cystic carcinoma is a rare tumor. Compared with other nasopharyngeal tumors, it is characterized by its slow evolution but is locally aggressive and has a high tendency to recurrence.
Wafa Bechairia +2 more
doaj +1 more source
Studying the abundance of heavy nuclei produced in carbon therapy using Geant4 toolkit [PDF]
مجله علوم و فنون هستهای, 2023 Carbon-12 ion beams in the energy range of 100-450 MeV/u have excellent conditions for radiation-resistant and deep-seated tumors. At energies above 400 MeV/u, radiation is significantly affected by nuclear fragmentation processes of increasing depth. In
S.M. Motevalli, V. Zanganeh, S. Bagheri
doaj +1 more source
A high-resolution large-area detector for quality assurance in radiotherapy. [PDF]
Sci RepHadron therapy is an advanced radiation modality for treating cancer, which currently uses protons and carbon ions. Hadrons allow for a highly conformal dose distribution to the tumour, minimising the detrimental side-effects due to radiation received by
Oliveira AM +9 more
europepmc +2 more sources
Systemic Treatment of Advanced Chordoma With Molecular Targeted Therapies: A Large Multicentre European Retrospective Case Series. [PDF]
Cancer Rep (Hoboken)ABSTRACT Background This retrospective series reports outcomes and prognostic factors for advanced chordoma (AC) treatment with molecular targeted therapies (MTTs) in different treatment lines. Methods This is a retrospective series of 57 patients with AC treated between 2004 and 2023 at one of seven participating sarcoma centres.
Lipplaa A +10 more
europepmc +2 more sources